Login to Your Account

Other News To Note

Wednesday, November 13, 2013

• Sinovac Biotech Ltd., of Beijing, said it was selected by the Jiangsu Centers for Disease Control and Prevention to supply the company’s inactivated hepatitis A vaccine, Healive, under the expanded program of immunization in 2014, to the pediatric population in Jiangsu Province.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription